(Q72797853)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7957541%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Fluvastatin efficacy and tolerability in comparison and in combination with cholestyramine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7957541%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

author name string

E Hagen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7957541%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

H Istad

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7957541%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

L Ose

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7957541%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

E Bodd

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7957541%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

H M Eriksen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7957541%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

V Selvig

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7957541%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

J M Bard

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7957541%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

J C Fruchart

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7957541%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

M Borge

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7957541%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

M C Wolf

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7957541%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7957541%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

29 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7957541%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7957541%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7957541%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

445-449

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7957541%20AND%20SRC:MED&resulttype=core&format=json

The efficacy and safety of pravastatin, compared to and in combination with bile acid binding resins, in familial hypercholesterolaemia

29 October 2019

cites work

1 reference

12 December 2020

Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levels

1 reference

12 December 2020

Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production.

1 reference

12 December 2020

Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I

1 reference

12 December 2020

How accurate is self-reported dietary energy intake?

1 reference

12 December 2020

A quarter century of drug treatment of dyslipoproteinemia, with a focus on the new HMG-CoA reductase inhibitor fluvastatin.

1 reference

12 December 2020

Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo

1 reference

12 December 2020

Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia. A multicenter study. The Lovastatin Study Group II

1 reference

12 December 2020

Pravastatin therapy in primary moderate hypercholesterolaemia: changes in metabolism of apolipoprotein B-containing lipoproteins

1 reference

12 December 2020

Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study

1 reference

12 December 2020

Accuracy of weighed dietary records in studies of diet and health

1 reference

12 December 2020

Cholestyramine in type II hyperlipoproteinemia. A double-blind trial

1 reference

12 December 2020

Effect of simvastatin on receptor-dependent low density lipoprotein catabolism in normocholesterolemic human volunteers

1 reference

12 December 2020

The recognition and management of hyperlipidaemia in adults: A policy statement of the European Atherosclerosis Society

1 reference

12 December 2020

Bile acid sequestrants: mechanisms of action on bile acid and cholesterol metabolism

1 reference

12 December 2020

Comparison of different HMG-CoA reductase inhibitors

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

12 December 2020

Are apolipoproteins better discriminators than lipids for atherosclerosis?

1 reference

12 December 2020

Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine

1 reference

12 December 2020

A selective bi-site immunoenzymatic procedure for human Lp[a] lipoprotein quantification using monoclonal antibodies against apo[a] and apoB.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00191909

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7957541%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference